ConductScience.org, home

Paper29902258

CRISPR-Cas antimicrobials: Challenges and future prospects.

Pursey E and 4 others. PLoS Pathog, 2018. Cited by 99 papers, by iCite.

Cite this record

ConductScience Library. CRISPR-Cas antimicrobials: Challenges and future prospects. Papers, record 29902258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29902258

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CRISPR-Cas antimicrobials: Challenges and future prospects.
PubMed
Journal
PLoS Pathog
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
99
iCite
Relative citation ratio, by iCite
4.21
iCite
Revised in PubMed
2023-08-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pursey EElizabethhttps://orcid.org/0000-0001-8067-4440
2Sünderhauf DDavidhttps://orcid.org/0000-0002-8007-3351
3Gaze WHWilliam H
4Westra EREdze Rhttps://orcid.org/0000-0003-4396-0354
5van Houte SStinekehttps://orcid.org/0000-0001-7047-1308

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
BacteriaMajor topic
CRISPR-Cas SystemsMajor topic
Gene EditingMajor topic
Gene Expression Regulation, BacterialMajor topic
Microbial ViabilityMajor topic
Genetic Engineering
Transformation, Bacterial

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
BB/R010781/1Biotechnology and Biological Sciences Research CouncilUnited KingdomPubMed
MR/N007174/1Medical Research CouncilUnited KingdomPubMed
109776/Z/15/ZWellcome TrustUnited KingdomPubMed
Wellcome TrustUnited KingdomPubMed
BB/N017412/1Biotechnology and Biological Sciences Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125282355Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.Nat Biotechnol2014https://conductscience.org/library/papers/25282355PubMed
226190075Parallel compensatory evolution stabilizes plasmids across the parasitism-mutualism continuum.Curr Biol2015https://conductscience.org/library/papers/26190075PubMed
317059480Frequent conjugative transfer accelerates adaptation of a broad-host-range plasmid to an unfavorable Pseudomonas putida host.FEMS Microbiol Ecol2007https://conductscience.org/library/papers/17059480PubMed
424692635Metatranscriptomics of the human oral microbiome during health and disease.mBio2014https://conductscience.org/library/papers/24692635PubMed
528749735The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.Annu Rev Virol2017https://conductscience.org/library/papers/28749735PubMed
626411297An updated evolutionary classification of CRISPR-Cas systems.Nat Rev Microbiol2015https://conductscience.org/library/papers/26411297PubMed
727250768Genetically Engineered Phages: a Review of Advances over the Last Decade.Microbiol Mol Biol Rev2016https://conductscience.org/library/papers/27250768PubMed
825240928Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.Nat Biotechnol2014https://conductscience.org/library/papers/25240928PubMed
927941126Evolution of Resistance Against CRISPR/Cas9 Gene Drive.Genetics2017https://conductscience.org/library/papers/27941126PubMed
1028844692A Broad-Spectrum Inhibitor of CRISPR-Cas9.Cell2017https://conductscience.org/library/papers/28844692PubMed
1124086164Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids.PLoS Genet2013https://conductscience.org/library/papers/24086164PubMed
1229396999Progress of CRISPR-Cas Based Genome Editing in Photosynthetic Microbes.Biotechnol J2018https://conductscience.org/library/papers/29396999PubMed
1327836667Exploring the potential of genome editing CRISPR-Cas9 technology.Gene2017https://conductscience.org/library/papers/27836667PubMed
1424445449Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection.Nat Commun2014https://conductscience.org/library/papers/24445449PubMed
1529062071Anti-CRISPR: discovery, mechanism and function.Nat Rev Microbiol2018https://conductscience.org/library/papers/29062071PubMed
1624473129Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems.mBio2014https://conductscience.org/library/papers/24473129PubMed
1728232956Scaffolding bacterial genomes and probing host-virus interactions in gut microbiome by proximity ligation (chromosome capture) assay.Sci Adv2017https://conductscience.org/library/papers/28232956PubMed
1819713526Functional characterization of the antibiotic resistance reservoir in the human microflora.Science2009https://conductscience.org/library/papers/19713526PubMed
1926060300Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26060300PubMed
2028469274CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum.Nat Commun2017https://conductscience.org/library/papers/28469274PubMed

See all 34 referencesDownload CSV of references

Cited by79

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.

PMIDTitleJournalYearIn PapersSource
42678547CRISPR-cas systems in pharmacology: functional pharmacogenomics, drug screening, resistance, and therapeutic translation.Funct Integr Genomics2026https://conductscience.org/library/papers/42678547PubMed
42637903"Lariocidin and ribosome-targeting lasso peptides as emerging antimicrobial agents against multidrug-resistant bacteria".J Antibiot (Tokyo)2026https://conductscience.org/library/papers/42637903PubMed
42554845CRISPR/Cas system as a novel therapeutic strategy to combat multi-drug-resistant bacteria.Arch Microbiol2026https://conductscience.org/library/papers/42554845PubMed
42529233Identification, resistance mechanisms, and innovative therapeutic approaches against Acinetobacter baumannii-calcoaceticus complex.Front Microbiol2026https://conductscience.org/library/papers/42529233PubMed
42497250Energy-assisted CRISPR cleavage and probiotic vesicle signaling platform: Microbiome reprogramming for homeostasis.Sci Adv2026https://conductscience.org/library/papers/42497250PubMed
42451761Next-Generation Strategies to Encounter Antimicrobial Resistance (AMR): From Lariocidin to Gene Editing and Nanotechnology-Based Approaches.Molecules2026https://conductscience.org/library/papers/42451761PubMed
42347171Bacteriophage-Based Therapeutics for Bacterial Sexually Transmitted Infections: From Biological Barriers to Translational Strategies.Pathogens2026https://conductscience.org/library/papers/42347171PubMed
42211656CRISPR-driven strategies to disrupt methicillin-resistant Staphylococcus aureus biofilms: a review.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42211656PubMed
41994271
Next-generation bacteriophage therapeutic systems: CRISPR-based engineering, near-infrared bioimaging, and precision strategies for treating multidrug-resistant and extensively drug-resistant bacterial infections.
Front Microbiol2026https://conductscience.org/library/papers/41994271PubMed
41923586Emerging synthetic biology-assisted technologies for overcoming antibiotic resistance: CRISPR-Cas, bacteriophage, microbiome, and metabolic engineering-based solutions.J Microbiol2026https://conductscience.org/library/papers/41923586PubMed
41712626CRISPR-Cas is beneficial in plasmid competition, but limited by competitor toxin-antitoxin activity when horizontally transferred.PLoS Biol2026https://conductscience.org/library/papers/41712626PubMed
41600675Avian Pathogenic Escherichia coli: Advances in Pathogenesis, Diagnosis, and Control.Vet Sci2025https://conductscience.org/library/papers/41600675PubMed
41599772Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41599772PubMed
41599202CRISPR-Cas-Mediated Reprogramming Strategies to Overcome Antimicrobial Resistance.Pharmaceutics2026https://conductscience.org/library/papers/41599202PubMed
41333289Genomics, population dynamics, immune evasion and resistance determinants foster the competence and global dissemination of Klebsiella pneumoniae.PeerJ2025https://conductscience.org/library/papers/41333289PubMed
41085803CRISPR-Cas systems in combating antimicrobial resistance: which system to choose? A systematic review.World J Microbiol Biotechnol2025https://conductscience.org/library/papers/41085803PubMed
41009471The Gut Microbiome and Colistin Resistance: A Hidden Driver of Antimicrobial Failure.Int J Mol Sci2025https://conductscience.org/library/papers/41009471PubMed
40521034Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/40521034PubMed
40481260Antibiotic potentiators as a promising strategy for combating antibiotic resistance.NPJ Antimicrob Resist2025https://conductscience.org/library/papers/40481260PubMed
40447846Antibiotics re-booted-time to kick back against drug resistance.NPJ Antimicrob Resist2025https://conductscience.org/library/papers/40447846PubMed

See all 79 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29902258

GET https://conductscience.org/api/papers/v1/29902258/references?page=2